EUDA Health Holdings Ltd (EUDAW) Cost of Revenue (2022 - 2023)
EUDA Health Holdings' (EUDAW) quarterly Cost of Revenue came in at $64184.0 in Q2 2023, down 96.37% year-on-year from $1.8 million in Q2 2022, and down 95.04% on a QoQ basis from $1.3 million in Q1 2023.
EUDA Health Holdings Ltd (EUDAW) Cost of Revenue (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDAW) has 2 years of Cost of Revenue data on file, last reported at $64184.0 in Q2 2023.
- On a quarterly basis, Cost of Revenue fell 96.37% year-over-year to $64184.0 in Q2 2023; TTM through Jun 2023 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.8 million, up 17.81% from the prior year.
- Cost of Revenue for Q2 2023 stood at $64184.0, down from $1.3 million in the prior quarter.
- Over the last five years, Cost of Revenue for EUDAW reached as high as $1.8 million in Q2 2022 and fell as low as $64184.0 in Q2 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 64,184.00 |
| Jun 30, 2023 | 64,184.00 |
| Mar 31, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.40 Mn |